Logo image of ARAI

ARRIVE AI INC (ARAI) Stock Fundamental Analysis

NASDAQ:ARAI - Nasdaq - US04272H2040 - Common Stock - Currency: USD

6.77  -0.16 (-2.31%)

After market: 6.76 -0.01 (-0.15%)

Fundamental Rating

1

Overall ARAI gets a fundamental rating of 1 out of 10. We evaluated ARAI against 0 industry peers in the Unkown industry. Both the profitability and financial health of ARAI have multiple concerns. ARAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ARAI has reported negative net income.
ARAI had a negative operating cash flow in the past year.
ARAI Yearly Net Income VS EBIT VS OCF VS FCFARAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -459.39%
ROE N/A
ROIC N/A
ROA(3y)-578.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARAI Yearly ROA, ROE, ROICARAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 500 -500 1K -1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARAI Yearly Profit, Operating, Gross MarginsARAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for ARAI remains at a similar level compared to 1 year ago.
The debt/assets ratio for ARAI has been reduced compared to a year ago.
ARAI Yearly Shares OutstandingARAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
ARAI Yearly Total Debt VS Total AssetsARAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

ARAI has an Altman-Z score of 30.24. This indicates that ARAI is financially healthy and has little risk of bankruptcy at the moment.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 30.24
ROIC/WACCN/A
WACCN/A
ARAI Yearly LT Debt VS Equity VS FCFARAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

A Current Ratio of 0.31 indicates that ARAI may have some problems paying its short term obligations.
A Quick Ratio of 0.31 indicates that ARAI may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
ARAI Yearly Current Assets VS Current LiabilitesARAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

ARAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.03%, which is quite impressive.
EPS 1Y (TTM)38.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ARAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARAI Price Earnings VS Forward Price EarningsARAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARAI Per share dataARAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARRIVE AI INC

NASDAQ:ARAI (8/13/2025, 8:00:00 PM)

After market: 6.76 -0.01 (-0.15%)

6.77

-0.16 (-2.31%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.05%
Inst Owner ChangeN/A
Ins Owners76.01%
Ins Owner Change-2.42%
Market Cap223.55M
AnalystsN/A
Price TargetN/A
Short Float %6.52%
Short Ratio0.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -459.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-578.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 131.27%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 30.24
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1080.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.73%
OCF growth 3YN/A
OCF growth 5YN/A